Acute Porphyria Drug Database

Monograph

B06AA55 - Streptokinase, Combinations
Not porphyrinogenic
NP

Rationale
Enzyme. No CYP-interactions.
Chemical description
Fibrinolytic enzyme, solution for cutaneous and cavernous use in necrosis, abscesses, cellulits, decubitus etc.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes B06A / B06AA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
United Kingdom
Varidase Topical · Varidase Topical 125,000unit powder vials · Varidase Topical 125,000unit powder vials and diluent
Poland
Neostreptaza
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙